Vandetanib clinical trials

A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer

This study is testing a new drug called selpercatinib for a type of thyroid cancer that has spread or can't be removed by surgery. It wants to see if this new drug is safer and works better than current treatments for people with a specific gene change (RET mutation).